Skip to main content

ACADIAN ASSET MANAGEMENT LLC

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 916542 Boston, MA

Position in ACRS

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$5,774,216
-$614,204 QoQ
Shares Held
1,539,791
-27.5% QoQ
Ownership
1.10%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ACRS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

ACADIAN ASSET MANAGEMENT LLC holds $703,385,515 across 179 Biotechnology names. ACRS ranks #23 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACRS

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,774,216 1,539,791
2025-12-31 $6,388,420 2,122,399
2025-09-30 $4,421,336 2,327,019
2025-06-30 $3,456,067 2,433,850
2025-03-31 $3,358,642 2,195,191
2024-12-31 $4,325,484 1,744,147
2024-09-30 $2,390,030 2,078,287
2024-06-30 $2,104,793 1,913,449
2024-03-31 $2,647,855 2,135,367
2023-12-31 $2,468,977 2,351,407
2020-12-31 $552,292 85,362
2020-09-30 $499,083 194,196
2020-06-30 $153,629 94,833
2020-03-31 $18,876 18,150